This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
Tenet Healthcare (THC) concluded the recent trading session at $182.82, signifying a -2.1% move from its prior day's close.
HCA Healthcare Trades at a Premium: Buy, Hold, or Avoid the Stock?
by Kaibalya Pravo Dey
HCA trades above peers on valuation, backed by strong cash flow and buybacks, but weighed by debt and sector headwinds.
Here's Why Ensign Group Shares Are Attracting Investors Now
by Zacks Equity Research
ENSG stock is surging on revenue growth, acquisitions and raised 2025 earnings and sales guidance.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Pediatrix Medical Shares Are Attracting Investors Now
by Zacks Equity Research
MD shares surge on strong earnings, rising revenues, cost cuts and a new $250M buyback plan.
Tenet Healthcare (THC) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Fast-paced Mover Tenet (THC) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Tenet Healthcare (THC) closed at $191.78 in the latest trading session, marking a -2.35% move from the prior day.
Encompass Health Opens New Rehabilitation Hospital in The Villages
by Zacks Equity Research
EHC expands in Central Florida with a new 50-bed rehab hospital in The Villages, boosting its growth and patient care network.
Encompass Health Flexes Its Muscle: Margins Widen as Volumes Climb
by Kaibalya Pravo Dey
EHC's rising patient volumes, expanding footprint and tighter cost controls are fueling margin growth and a strong 2025 outlook.
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tenet Healthcare Jumps 46% YTD & Trades Cheap: Should You Buy Now?
by Kaibalya Pravo Dey
THC's 46% YTD surge, upgraded outlook, and discounted valuation highlight its strong growth potential.
Is it Time to Hold on to Community Health Systems Stock?
by Zacks Equity Research
CYH benefits from rising occupancy, higher revenue per admission, and business streamlining, supporting its case as a stock to retain in your portfolio.
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
by Zacks Equity Research
Humana teams up with Vori Health, HOPCo and TailorCare to expand value-based musculoskeletal care for Medicare Advantage members.
Universal Health Services (UHS) Up 11.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Acadia & ECU Health Expand Behavioral Care Access in North Carolina
by Zacks Equity Research
ACHC opens a 144-bed hospital with ECU Health in Greenville, NC, boosting care access and expanding its behavioral health reach.
Tenet (THC) Up 14.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Here's How Much a $1000 Investment in Tenet Healthcare Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.